It is time to end our love affair with short-acting β2-agonists in asthma

It is time to end our love affair with short-acting β2-agonists in asthma

Bibliographic Details
Main Authors:	Michael G. Crooks, Shoaib Faruqi
Format:	Article
Language:	English
Published:	European Respiratory Society 2022-10-01
Series:	ERJ Open Research
Online Access:	http://openres.ersjournals.com/content/8/4/00353-2022.full

Similar Items

It is time to end our love affair with short-acting β2-agonists in asthma? Yes
by: Luis J. Nannini
Published: (2023-02-01)

The carbon footprint associated with the overuse of short-acting β2-agonists in asthma patients
by: Chao-Hsien Chen, et al.
Published: (2024-01-01)

Short-acting β2-agonists and exacerbations in children with asthma in England: SABINA Junior
by: Ann Morgan, et al.
Published: (2023-04-01)

The prevalence and outcome of short-acting β2-agonists overuse in asthma patients in Taiwan
by: Cheng-Yi Wang, et al.
Published: (2021-04-01)

Healthcare costs associated with short-acting β2-agonists in asthma: observational UK SABINA study
by: Darush Attar-Zadeh, et al.
Published: (2023-09-01)

The controversial role of as-needed short-acting β2-agonist monotherapy in mild asthma: Short review of current guidelines
by: Couillard, S, et al.
Published: (2021)

Long-acting β2-adrenergic receptor agonist in pediatric asthma
by: Shigemi Yoshihara, et al.
Published: (2004-01-01)

Review: Safety of long-acting β2 -agonists in the treatment of asthma
by: Mario Cazzola, et al.
Published: (2007-10-01)

Correction: Healthcare costs associated with short-acting β2-agonists in asthma: observational UK SABINA study
Published: (2024-10-01)

Short-acting β2-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III
by: Arzu Yorgancıoğlu, et al.
Published: (2022-06-01)

Short-acting β2-agonist prescription patterns for asthma management in the SABINA III primary care cohort
by: David Price, et al.
Published: (2022-09-01)

Short-acting β2-agonist prescriptions in patients with asthma: findings from the South Korean cohort of SABINA III
by: Kwang-Ha Yoo, et al.
Published: (2024-01-01)

Over-prescription of short-acting β2-agonists for asthma in South Africa: Results from the SABINA III study
by: C Smith, et al.
Published: (2022-12-01)

Clinical Consequences of the Overuse of Short-Acting β2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study
by: Jesús Molina, et al.
Published: (2023-04-01)

Perceptions, attitudes, and behaviors of asthma patients towards the use of short-acting β2-agonists: A systematic review
by: Zhe Chi Loh, et al.
Published: (2023-01-01)

Perceptions, attitudes, and behaviors of asthma patients towards the use of short-acting β2-agonists: A systematic review.
by: Zhe Chi Loh, et al.
Published: (2023-01-01)

Over-prescription of short-acting β2-agonists and asthma management in the Gulf region: a multicountry observational study
by: Ashraf Alzaabi, et al.
Published: (2022-07-01)

Women newspaper editors in NZ: Short term love affair
by: Catherine Strong
Published: (2018-07-01)

β2-agonists in asthma
by: Britton, J, et al.
Published: (1991)

The italian love affair with sport
by: Narayana Astra van Amstel, et al.
Published: (2020-04-01)

Halligan’s Love Affair with Food
by: Anne Holden Rønning
Published: (2011-03-01)

Efficiency of using a short-acting β2-agonist for the relief of acute cold bronchospasm in asthma patients with cold airway hyperresponsiveness
by: A. G. Prihodko, et al.
Published: (2022-10-01)

Overprescription of short‐acting β2‐agonists among patients with asthma in Saudi Arabia: Results from the SABINA III cohort study
by: Hamdan Al‐Jahdali, et al.
Published: (2022-12-01)

MODERN VIEW ON THE LONG ACTING β2-AGONISTS IN THERAPY FOR THE BRONCHIAL ASTHMA AMONG CHILDREN
by: Yu.G. Levina, et al.
Published: (2008-05-01)

MODERN VIEW ON THE LONG ACTING β2-AGONISTS IN THERAPY FOR THE BRONCHIAL ASTHMA AMONG CHILDREN
by: Yu.G. Levina, et al.
Published: (2008-05-01)

Reducing short-acting beta-agonist use in asthma: Impact of national incentives on prescribing practices in England and the findings from SENTINEL Plus early adopter sites
by: M. G. Crooks, et al.
Published: (2024-04-01)

Something like a love affair /
by: 536568 Symons, Julian
Published: (1992)

Poetry is a Love Affair with Life
by: Natalia Efimovna Carmona
Published: (2002-12-01)

Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonists
by: Willson, J, et al.
Published: (2014)

Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonists.
by: Willson, J, et al.
Published: (2014)

Burden of illness among patients with asthma prescribed inhaled corticosteroids/long-acting β2-agonists
by: Shiyuan Zhang, et al.
Published: (2025-02-01)

Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States
by: Carlyne M. Averell, et al.
Published: (2022-08-01)

Overprescription of short-acting β2 agonists: reflections from the SABINA study in Brazil
by: Martti Anton Antila, et al.
Published: (2024-02-01)

Factors Associated with Failure of Intermittent Nebulization with Short-Acting Beta-Agonists in Children with Severe Asthma Exacerbation
by: Kulalert P, et al.
Published: (2020-08-01)

Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma
by: Leanne Kaye, et al.
Published: (2022-09-01)

Over-the-counter short-acting β2-agonist purchase and asthma-related health outcomes: a post hoc analysis of the SABINA III study
by: David Price, et al.
Published: (2024-11-01)

The end of the affair /
by: Greene, Graham, 1904-1991
Published: (1951)

Author Correction: Reducing short-acting beta-agonist use in asthma: Impact of national incentives on prescribing practices in England and the findings from SENTINEL Plus early adopter sites
by: M. G. Crooks, et al.
Published: (2024-07-01)

Combined therapy with inhaled glucocorticosteroids and long-acting β2-agonists in patients with bronchial asthma: the problem of choice
by: A. I. Sinopalnikov
Published: (2021-10-01)

Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany
by: Heinrich Worth, et al.
Published: (2021-04-01)